Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
Using more predictive single cell proteomics in mouse models to understand correlative T cell potency in infectious disease vaccines
Understanding of more predictive T cell potency in mouse models important for understanding vaccine development
The challenges in pre-clinical vaccine development today that can be overcome by having potency tools and better ways to characterize human immune response
